AstraZeneca PLC

Pharmaceuticals
United Kingdom
Executive 1Pascal Soriot, Chief Executive Officer; | Chief Executive Officer;
Executive 2Marc Dunoyer, Chief Financial Officer; | Vice-Chairman;
Earnings Per Share Growth (%)-51.96%
Cost of Goods Sold (US$ Millions)$5,842
Current Liabilities (US$ Millions)$17,330
Total Assets (US$ Millions)$16,697
Long Term Debt (Millions)$8,397
Return on Equity5.32%
Revenue (US$ Millions)$26,882
Total Company Assets$58,595
Revenue Growth (%)2.19%
Net Income (US$ Millions)$1,235
Earnings Per Share (US$)$0.98
Total Equity (US$ Millions)$19,627
Profit Margin (%)4.59%
Debt To Equity Ratio (%)0.43%
Inventories (Millions)$1,960